Current Trends in Phyto-cancer Therapy Using Nanoparticles

Author:

Vohra K.1,Dureja H.1,Garg V.1,Dutt R.2

Affiliation:

1. Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India

2. School of Medical and Allied Sciences, GD Goenka University, Gurugram, Haryana, India

Abstract

Background:Cancer has been considered as a deadly disease and its appropriate management is still a global challenge. The traditional anticancer therapeutics have been able to combat the disease to some extent but with numerous adverse effects which affect the quality of life of patients.Method:The introduction of alternative medicines, especially herbal medicines, has attracted the scientists’ due to low toxicity and high efficacy associated with them. However, their poor solubility and bioavailability decrease their efficacy. This has led to the increased use of targeted drug delivery systems in phyto-cancer therapy.Results:Nanoparticles (NPs), a novel drug delivery system has been widely used in the recent years due to their various advantages such as drug targeting, improved solubility, and bioavailability, high efficacy, low toxicity towards normal cells, low drug resistance, high drug loading at tumor site, etc.Conclusion:These benefits have also been observed in studies evaluating phytonanotherapy in cancer. The present review highlights current trends followed by phyto-cancer therapy using NPs. The recent studies conducted on herbal NPs for cancer therapy have also been enlisted.

Funder

Haryana State Council for Science and Technology

Publisher

Bentham Science Publishers Ltd.

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Reference150 articles.

1. WHO, . http: //www.who.int/mediacentre/ factsheets/fs297/en/, Cancer Factsheet 2017 [5 May, 2017]. Available from:,

2. UK CR, . http: //www.cancerresearchuk. org/health-professional/cancer-statistics/worldwide-cancer, Worldwide Cancer Statistics2012 [24 May, 2017]. Available from:,

3. Dikshit R, Gupta PC, Ramasundarahettige C. The Lancet, Cancer mortality in India: a nationally representative survey.,, 2012, 379,, 1807-1816

4. Mallath MK, Taylor DG, Badwe RA. The Lancet Oncol, The growing burden of cancer in India: epidemiology and social context.,, 2014, 15,, e205-e12

5. ICMR. Over 17 lakh new cancer cases in India by 2020 2016 [29 August, 2017]. Available from:, . http: //icmr.nic.in/icmrsql/archive/2016/7.pdf, ,

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Phyto-Nanoparticles in Osteogenesis;Innovation in Osteogenesis Research [Working Title];2024-06-20

2. Nanotherapeutics in glioma management: Advances and future perspectives;Journal of Drug Delivery Science and Technology;2020-06

3. Nanophytomedicine: An Effective Way for Improving Drug Delivery and Bioavailability of Herbal Medicines;Nanophytomedicine;2020

4. Anticancer Drug-Loaded Nanoparticulate Drug Delivery;Current Nanomedicine;2019-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3